Table 2.

Frequency of clinical parameters and raised immunohistochemical markers in NSCLC tumour specimens

Parameters	Total
Total	79	EGFR	cerbB2	cerbB3	bcl-2	p53	Ki-67	p120	MVD
Clinical parameters
AC	37	11	16	17	16	13	13	21	11
SCC	37	19	12	27	7	15	24	23	17
LCC	3	1	1	2	2	1	0	1	1
Carcinoid	2	1	0	0	1	0	0	1	0
Death	26	9	10	18	7	10	11	14	10
IHC
EGFR	32	–	10	22	9	9	18	19	10
c-erbB-2	29	10	–	21	8	12	15	22	5
c-erbB-3	46	22	21	–	12	18	28	31	18
bcl-2	26	9	8	12	–	8	12	13	11
p53	29	9	12	18	8	–	18	22	12
Ki-67	36	18	15	28	12	18	–	25	13
p120	46	19	22	31	13	22	25	–	19
MVD	29	10	5	18	11	12	13	19	–
CD3	7	2	2	5	4	4	3	3	2
CD19	39	14	16	26	17	17	21	21	5

The bold numbers indicate a significant correlation between the two parameters (Pearson χ² test, p < 0.05).

AC, adenocarcinoma; EGFR, epidermal growth factor; IHC, immunohistochemistry; LCC, large cell carcinoma; NSCLC, non-small cell lung cancer; MVD, microvessel density; SCC, small cell carcinoma.